Condition

Monkeypox (3)

Smallpox (2)

Antiviral Agents (1)

Overall Status

Not yet recruiting (2)

Available (1)

Completed (1)

Phase

phase 3 (3)

Sponsor

Calmy Alexandra (1)

Marina Klein (1)

SIGA Technologies (1)

U.S. Army Medical Research and Development Command (1)

Collaborator

ANRS, Emerging Infectious Diseases (1)

Biomedical Advanced Research and Development Authority (1)

CIHR Canadian HIV Trials Network (1)

McGill University Health Centre/Research Institute of the McGill University Health Centre (1)

Oswaldo Cruz Foundation (1)

Unity Health Toronto (1)

University Health Network, Toronto (1)

University of British Columbia (1)

Intervention

tecovirimat (4)

placebo (3)

Study Documents

Intervention Type

drug (4)

other (1)

Funder Type

Other (2)

Industry (1)

U.S. Fed (1)

Study Type

Interventional (3)

Expanded Access (1)

tecovirimat

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Smallpox, Monkeypox Trial (Tecovirimat)

Available

Smallpox
Monkeypox

Tecovirimat

(no location specified)

Jul 20, 2022

Monkeypox Trial (Tecovirimat, Placebo)

Not yet recruiting

Monkeypox

Tecovirimat
Placebo

(no location specified)

Sep 7, 2022

Monkeypox, Antiviral Agents Trial in Brazil, Switzerland (Tecovirimat, Placebo)

Not yet recruiting

Monkeypox
Antiviral Agents

Tecovirimat
Placebo

Belo Horizonte, Brazil
+8 more

Oct 28, 2022

Smallpox Trial in United States (tecovirimat, Placebo)

Completed

Has Results

Smallpox

tecovirimat
Placebo

Mobile, Alabama
+10 more

Oct 20, 2017